Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Deferred Taxes (2022 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Deferred Taxes for 4 consecutive years, with -$46000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Deferred Taxes rose 98.61% year-over-year to -$46000.0, compared with a TTM value of -$1.3 million through Sep 2025, up 75.83%, and an annual FY2024 reading of -$3.8 million, down 250.1% over the prior year.
  • Deferred Taxes was -$46000.0 for Q3 2025 at Bicycle Therapeutics, up from -$331000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $7.3 million in Q3 2023 and bottomed at -$3.3 million in Q3 2024.
  • Average Deferred Taxes over 4 years is -$528533.3, with a median of -$868000.0 recorded in 2022.
  • The sharpest move saw Deferred Taxes surged 810.06% in 2023, then plummeted 200.91% in 2025.
  • Year by year, Deferred Taxes stood at -$2.3 million in 2022, then soared by 53.98% to -$1.1 million in 2023, then soared by 139.07% to $420000.0 in 2024, then tumbled by 110.95% to -$46000.0 in 2025.
  • Business Quant data shows Deferred Taxes for BCYC at -$46000.0 in Q3 2025, -$331000.0 in Q2 2025, and -$1.3 million in Q1 2025.